Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ann Thor

Concepts (434)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
64
2022
1781
4.440
Why?
Receptor, ErbB-2
24
2018
301
3.010
Why?
Metformin
10
2018
283
2.460
Why?
Tamoxifen
10
2020
187
1.720
Why?
Receptors, Estrogen
15
2020
368
1.610
Why?
Receptor, ErbB-3
8
2016
42
1.500
Why?
Cell Proliferation
15
2018
2158
1.320
Why?
Genes, erbB-2
8
2013
24
1.270
Why?
Mammary Neoplasms, Experimental
6
2017
61
1.210
Why?
Apoptosis
20
2018
2319
0.900
Why?
Cell Line, Tumor
22
2020
2669
0.840
Why?
Thyroid Hormones
1
2020
54
0.780
Why?
Hormone Replacement Therapy
1
2020
75
0.760
Why?
Up-Regulation
3
2020
793
0.760
Why?
Triple Negative Breast Neoplasms
3
2016
151
0.710
Why?
Mammary Neoplasms, Animal
3
2018
29
0.700
Why?
Disease-Free Survival
11
2020
633
0.670
Why?
Tumor Suppressor Protein p53
13
2011
444
0.640
Why?
Immunohistochemistry
24
2017
1603
0.640
Why?
Neoplasms, Germ Cell and Embryonal
3
2023
47
0.620
Why?
Hypoglycemic Agents
3
2017
621
0.610
Why?
Biomarkers, Tumor
10
2021
984
0.600
Why?
Testicular Neoplasms
3
2023
82
0.600
Why?
Gene Expression Regulation, Neoplastic
18
2021
1114
0.600
Why?
ErbB Receptors
4
2010
565
0.590
Why?
Claudins
1
2016
21
0.570
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1365
0.560
Why?
Antineoplastic Agents
9
2018
1929
0.550
Why?
Receptor, IGF Type 1
3
2016
55
0.550
Why?
Transcriptome
1
2020
704
0.540
Why?
Carcinogenesis
1
2016
157
0.510
Why?
Prognosis
17
2016
3245
0.500
Why?
Carcinoma, Ductal, Breast
5
2002
70
0.500
Why?
Cell Cycle
4
2013
509
0.490
Why?
Estradiol
2
2009
462
0.480
Why?
Trastuzumab
7
2016
90
0.480
Why?
Lymphatic Metastasis
16
2021
227
0.470
Why?
Caspases
4
2009
259
0.470
Why?
Genistein
2
2010
20
0.460
Why?
Female
64
2022
58205
0.430
Why?
Antineoplastic Agents, Hormonal
5
2020
138
0.430
Why?
Signal Transduction
15
2018
4136
0.430
Why?
Receptors, Steroid
1
2012
55
0.430
Why?
Antimetabolites, Antineoplastic
1
2012
76
0.420
Why?
Drug Resistance, Neoplasm
9
2016
671
0.400
Why?
Neoplasm Invasiveness
7
2016
399
0.390
Why?
STAT3 Transcription Factor
1
2012
175
0.380
Why?
Genes, p53
5
2000
53
0.380
Why?
Humans
81
2023
109574
0.370
Why?
Neoplasm Proteins
5
2016
382
0.350
Why?
Glucose
1
2013
872
0.340
Why?
Glycoproteins
2
2005
296
0.330
Why?
Intracellular Signaling Peptides and Proteins
2
2010
384
0.330
Why?
Mice, Transgenic
8
2018
1591
0.320
Why?
Mammary Tumor Virus, Mouse
2
2004
18
0.320
Why?
MCF-7 Cells
4
2020
113
0.300
Why?
MicroRNAs
4
2021
580
0.300
Why?
Carcinoma
4
1995
193
0.300
Why?
Doxorubicin
9
2011
285
0.280
Why?
Polymerase Chain Reaction
6
2021
853
0.280
Why?
Bromodeoxyuridine
2
1999
71
0.280
Why?
Mice
16
2022
12565
0.270
Why?
Protein Kinase Inhibitors
3
2016
841
0.270
Why?
Antibodies, Monoclonal
6
2013
1052
0.270
Why?
Animals
22
2022
29555
0.270
Why?
Xenograft Model Antitumor Assays
3
2020
728
0.260
Why?
Tyrosine
2
2007
185
0.260
Why?
Radiation Tolerance
1
2005
97
0.260
Why?
Quinazolines
2
2016
241
0.250
Why?
Phosphorylation
5
2011
1468
0.250
Why?
Cocarcinogenesis
1
2003
8
0.240
Why?
Isoflavones
1
2003
22
0.240
Why?
Cell Survival
5
2018
959
0.240
Why?
Paclitaxel
4
2015
186
0.240
Why?
Seminoma
1
2023
15
0.240
Why?
Chromosomes
1
2003
73
0.230
Why?
Multivariate Analysis
7
2005
1455
0.230
Why?
Receptors, Progesterone
5
2012
315
0.230
Why?
Cyclins
2
2000
69
0.220
Why?
Chromosomes, Human, Pair 8
1
2002
34
0.220
Why?
Chromosome Aberrations
1
2002
126
0.220
Why?
Enzyme Activation
3
2009
711
0.210
Why?
Ki-67 Antigen
3
2014
102
0.210
Why?
Cyclophosphamide
7
2011
217
0.210
Why?
Breast
4
2018
126
0.210
Why?
Orchiectomy
1
2021
56
0.210
Why?
Diet
3
2018
1053
0.210
Why?
Retroperitoneal Neoplasms
1
2021
16
0.210
Why?
Neoplasm Staging
8
2021
1105
0.200
Why?
Obesity
4
2022
2619
0.200
Why?
Survival Analysis
7
2005
1213
0.200
Why?
Rats
7
2022
5346
0.200
Why?
Neoplastic Stem Cells
2
2014
325
0.190
Why?
Teratoma
1
2021
85
0.190
Why?
Phosphatidylinositol 3-Kinases
3
2011
304
0.190
Why?
TOR Serine-Threonine Kinases
3
2012
354
0.190
Why?
Mice, SCID
1
2020
276
0.190
Why?
Ovarian Neoplasms
4
1995
381
0.190
Why?
Middle Aged
26
2021
26782
0.190
Why?
Mice, Inbred NOD
1
2020
335
0.180
Why?
Carcinoma, Papillary
1
1999
61
0.180
Why?
Antigens, Neoplasm
2
2009
156
0.180
Why?
Autism Spectrum Disorder
1
2023
258
0.180
Why?
Mitotic Index
1
1999
24
0.180
Why?
Proto-Oncogene Proteins
5
2008
593
0.180
Why?
Chemotherapy, Adjuvant
5
2015
288
0.180
Why?
Receptors, Androgen
2
2017
124
0.170
Why?
Aromatase
1
2018
29
0.170
Why?
Drug Synergism
3
2018
317
0.170
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.170
Why?
Kaplan-Meier Estimate
1
2020
847
0.160
Why?
HSP90 Heat-Shock Proteins
1
2018
44
0.160
Why?
Phenylthiohydantoin
2
2017
40
0.160
Why?
Ovariectomy
4
2022
119
0.160
Why?
Fluorouracil
5
2009
133
0.160
Why?
Down-Regulation
3
2010
569
0.160
Why?
Tumor Burden
4
2022
244
0.160
Why?
In Situ Hybridization, Fluorescence
4
2008
308
0.160
Why?
Poly(ADP-ribose) Polymerases
2
2009
83
0.160
Why?
Cell Division
4
2005
679
0.160
Why?
Estrogen Receptor alpha
2
2018
117
0.150
Why?
Organic Cation Transport Proteins
1
2017
28
0.150
Why?
Postmenopause
5
2022
301
0.150
Why?
Triazoles
1
2018
128
0.150
Why?
Caspase 3
3
2006
238
0.150
Why?
Smad Proteins
1
2016
30
0.140
Why?
Gene Knock-In Techniques
1
2016
36
0.140
Why?
Ovary
1
2017
202
0.140
Why?
Calcitriol
1
2016
51
0.140
Why?
Receptor Protein-Tyrosine Kinases
1
2018
246
0.140
Why?
Estrogens
1
2018
305
0.140
Why?
Proteins
2
1992
836
0.140
Why?
Protein Tyrosine Phosphatases
1
2016
102
0.140
Why?
Drug Screening Assays, Antitumor
2
2016
180
0.130
Why?
Gene Amplification
2
2009
97
0.130
Why?
Mental Disorders
1
2023
893
0.130
Why?
Fatty Acid Synthase, Type I
1
2014
7
0.130
Why?
Mice, Knockout
1
2020
2224
0.130
Why?
Disease Progression
6
2018
2212
0.130
Why?
Immunoradiometric Assay
1
1994
1
0.130
Why?
Cathepsin D
1
1994
7
0.130
Why?
Antibodies, Monoclonal, Humanized
4
2013
623
0.130
Why?
Postpartum Period
2
2014
261
0.130
Why?
Adenocarcinoma
3
2012
661
0.130
Why?
Immunoprecipitation
2
2011
149
0.130
Why?
Androgen Receptor Antagonists
1
2014
31
0.120
Why?
Tumor Cells, Cultured
5
2009
825
0.120
Why?
Insulin-Like Growth Factor I
1
2016
276
0.120
Why?
Transforming Growth Factor beta
1
2016
399
0.120
Why?
Androgen Antagonists
1
2014
76
0.120
Why?
Receptor, ErbB-4
2
2010
19
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
59
0.120
Why?
Disease Models, Animal
4
2017
3439
0.110
Why?
Blotting, Western
3
2011
1135
0.110
Why?
Nucleic Acid Hybridization
2
2003
148
0.110
Why?
Vitamin D
1
2016
348
0.110
Why?
Overnutrition
1
2012
37
0.110
Why?
RNA, Messenger
4
2016
2420
0.110
Why?
Aminosalicylic Acids
1
2012
7
0.110
Why?
DNA, Neoplasm
6
2005
146
0.110
Why?
Benzenesulfonates
1
2012
20
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
193
0.110
Why?
Gene Expression Profiling
2
2016
1460
0.110
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
43
0.110
Why?
Chromones
1
2011
35
0.110
Why?
Dasatinib
1
2011
44
0.110
Why?
Genital Diseases, Female
1
1991
27
0.100
Why?
Mitosis
3
2001
133
0.100
Why?
Fluoxymesterone
1
1991
3
0.100
Why?
Cohort Studies
2
2020
4802
0.100
Why?
Proportional Hazards Models
4
2005
1097
0.100
Why?
Apoptosis Regulatory Proteins
1
2012
158
0.100
Why?
S Phase
2
2010
61
0.100
Why?
Thiazoles
1
2011
109
0.100
Why?
Morpholines
1
2011
99
0.100
Why?
Reagent Kits, Diagnostic
1
1991
42
0.100
Why?
Genital Neoplasms, Female
1
1991
62
0.100
Why?
Flow Cytometry
3
2007
850
0.100
Why?
Weight Gain
3
2022
488
0.100
Why?
Neoplasm Metastasis
5
2005
562
0.100
Why?
Chromosomes, Human, Pair 17
3
2002
58
0.100
Why?
Proto-Oncogenes
1
1989
27
0.090
Why?
Antibiotics, Antineoplastic
2
2009
106
0.090
Why?
Radioisotopes
1
1989
28
0.090
Why?
Aged
12
2015
19244
0.090
Why?
Adult
15
2021
29923
0.090
Why?
Dose-Response Relationship, Drug
2
2008
1930
0.090
Why?
Anthracyclines
1
2009
38
0.090
Why?
DNA Topoisomerases, Type II
1
2009
43
0.090
Why?
DNA-Binding Proteins
2
2009
1168
0.090
Why?
Treatment Outcome
5
2007
8988
0.090
Why?
Gene Deletion
2
2002
291
0.080
Why?
Mutation
3
1995
2977
0.080
Why?
Pyrimidines
1
2011
372
0.080
Why?
Epithelial Cells
1
2014
882
0.080
Why?
MAP Kinase Signaling System
1
2010
273
0.080
Why?
AMP-Activated Protein Kinases
1
2009
168
0.080
Why?
RNA, Small Interfering
2
2007
531
0.080
Why?
Protein Structure, Tertiary
1
2009
653
0.080
Why?
Transcription Factors
2
2008
1319
0.080
Why?
Mice, Nude
1
2009
614
0.080
Why?
Gene Dosage
1
2008
136
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
921
0.080
Why?
Immunoenzyme Techniques
3
1999
189
0.080
Why?
Time Factors
4
2015
6376
0.080
Why?
Energy Metabolism
1
2012
853
0.070
Why?
Proto-Oncogene Proteins c-akt
3
2016
408
0.070
Why?
Enzyme Precursors
1
2006
13
0.070
Why?
Mitochondria
3
2008
724
0.070
Why?
Epigenesis, Genetic
1
2010
483
0.070
Why?
Receptor, Notch1
1
2006
63
0.070
Why?
Herpesvirus 1, Human
1
2006
58
0.070
Why?
Multigene Family
2
2003
167
0.070
Why?
Lamin Type B
1
2005
6
0.070
Why?
Herpes Simplex
1
2006
81
0.070
Why?
Tumor Microenvironment
2
2018
386
0.070
Why?
Age Factors
3
2003
2922
0.070
Why?
Cell Nucleolus
1
2005
17
0.070
Why?
Nitriles
2
2017
158
0.070
Why?
Benzamides
2
2017
171
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
106
0.070
Why?
Protein Kinases
1
2006
227
0.070
Why?
Follow-Up Studies
4
2007
4461
0.070
Why?
Feedback
1
2005
138
0.070
Why?
Aged, 80 and over
4
2000
6464
0.060
Why?
RNA Interference
3
2015
432
0.060
Why?
Tacrolimus Binding Protein 1A
1
2003
5
0.060
Why?
Tacrolimus Binding Proteins
1
2003
14
0.060
Why?
Predictive Value of Tests
4
2011
1767
0.060
Why?
Rats, Wistar
2
2017
358
0.060
Why?
Mice, Inbred Strains
1
2004
294
0.060
Why?
Estrogens, Non-Steroidal
1
2003
4
0.060
Why?
Genes, Tumor Suppressor
1
2003
69
0.060
Why?
Adipose Tissue
2
2018
612
0.060
Why?
Lymph Node Excision
2
2021
111
0.060
Why?
Phytoestrogens
1
2003
15
0.060
Why?
Plant Preparations
1
2003
20
0.060
Why?
Cell Line
2
2003
2310
0.060
Why?
Estrogen Antagonists
1
2003
37
0.060
Why?
Actins
1
2005
344
0.060
Why?
Chromosome Banding
1
2002
18
0.060
Why?
Anticarcinogenic Agents
1
2003
73
0.060
Why?
Chromosomes, Human, Pair 16
1
2002
28
0.060
Why?
Mammary Glands, Animal
1
2003
133
0.060
Why?
Rodentia
1
2022
46
0.060
Why?
Transfection
3
2015
780
0.060
Why?
3' Untranslated Regions
2
2014
138
0.060
Why?
Trefoil Factor-1
2
1992
2
0.050
Why?
Nuclear Proteins
2
2000
536
0.050
Why?
alpha-Fetoproteins
1
2021
33
0.050
Why?
Fallopian Tubes
2
1991
23
0.050
Why?
In Situ Nick-End Labeling
1
2001
124
0.050
Why?
Sweden
1
2021
44
0.050
Why?
Chorionic Gonadotropin
1
2021
79
0.050
Why?
RNA, Catalytic
1
2002
157
0.050
Why?
Plasmids
1
2002
306
0.050
Why?
Neoplasm, Residual
1
2021
82
0.050
Why?
RNA Stability
1
2021
75
0.050
Why?
Antigens, Nuclear
1
2000
16
0.050
Why?
Breast Diseases
1
2000
16
0.050
Why?
Enhancer Elements, Genetic
1
2000
124
0.050
Why?
Reproducibility of Results
2
2021
2713
0.050
Why?
Telomerase
1
2001
177
0.050
Why?
Integrin beta3
2
2013
10
0.050
Why?
Tumor Suppressor Proteins
2
1992
261
0.050
Why?
Trans-Activators
1
2000
270
0.040
Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
Why?
DNA Glycosylases
1
1998
6
0.040
Why?
Methylnitrosourea
1
2018
6
0.040
Why?
Retrospective Studies
4
2005
11697
0.040
Why?
Loss of Function Mutation
1
2018
34
0.040
Why?
G2 Phase Cell Cycle Checkpoints
1
2018
41
0.040
Why?
Case-Control Studies
2
2023
2989
0.040
Why?
Antibodies
1
2000
333
0.040
Why?
NF-kappa B
1
2002
630
0.040
Why?
Codon
3
1993
80
0.040
Why?
Half-Life
1
2018
138
0.040
Why?
Stromal Cells
1
2018
91
0.040
Why?
Hyaluronan Receptors
1
1998
76
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
136
0.040
Why?
Organic Cation Transporter 2
1
2017
9
0.040
Why?
Gene Expression
3
2013
1365
0.040
Why?
Antigens, CD
2
2014
377
0.040
Why?
Extracellular Matrix Proteins
1
1998
115
0.040
Why?
DNA Repair
1
1998
178
0.040
Why?
Steroids
1
2017
148
0.040
Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
11
0.040
Why?
RNA
1
2001
648
0.040
Why?
Chromatography, Liquid
1
2017
317
0.040
Why?
Phosphatidylinositol 3-Kinase
1
2015
21
0.030
Why?
Oncogenes
1
2016
116
0.030
Why?
Survival Rate
3
1998
1657
0.030
Why?
Oncogene Proteins
1
1995
48
0.030
Why?
Cell Nucleus
3
2006
510
0.030
Why?
Homeodomain Proteins
1
2018
415
0.030
Why?
Mass Spectrometry
1
2017
568
0.030
Why?
Testosterone
1
2017
320
0.030
Why?
Tosyl Compounds
1
2014
17
0.030
Why?
Integrin alpha6
1
2013
7
0.030
Why?
Antigens, Differentiation, Myelomonocytic
1
2014
43
0.030
Why?
Leukocyte Common Antigens
1
2014
66
0.030
Why?
Mammary Glands, Human
1
2014
65
0.030
Why?
Analysis of Variance
2
2014
1335
0.030
Why?
Neoplasms
2
2012
2055
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2015
269
0.030
Why?
Parity
1
2014
99
0.030
Why?
Brain Neoplasms
2
1993
982
0.030
Why?
Immunoassay
1
1994
91
0.030
Why?
Sirolimus
2
2006
190
0.030
Why?
Premenopause
1
2014
117
0.030
Why?
Anilides
1
2014
72
0.030
Why?
Transplantation, Heterologous
1
2014
185
0.030
Why?
Interleukin-6
1
2017
637
0.030
Why?
bcl-2-Associated X Protein
2
2007
35
0.030
Why?
Neovascularization, Pathologic
1
1995
271
0.030
Why?
Neoplasm Transplantation
1
2014
217
0.030
Why?
Organ Specificity
1
2013
239
0.030
Why?
Inhibitor of Apoptosis Proteins
1
2013
43
0.030
Why?
Immune System
1
2014
151
0.030
Why?
Young Adult
2
2021
10138
0.030
Why?
Lactation
1
2014
176
0.030
Why?
Lipogenesis
1
2012
70
0.030
Why?
Point Mutation
1
1993
200
0.030
Why?
Astrocytoma
1
1993
107
0.030
Why?
Molecular Targeted Therapy
1
2015
359
0.030
Why?
Broad Ligament
1
1991
2
0.030
Why?
Tumor Necrosis Factor-alpha
2
2007
1070
0.030
Why?
Gene Knockdown Techniques
1
2013
295
0.030
Why?
Peritoneum
1
1991
30
0.030
Why?
Glycolysis
1
2012
228
0.030
Why?
Mucins
1
1991
60
0.030
Why?
Pilot Projects
1
2015
1320
0.030
Why?
Pregnancy Complications, Neoplastic
1
1991
49
0.030
Why?
Pregnancy
2
2014
5275
0.030
Why?
Blotting, Northern
1
2010
172
0.030
Why?
Evaluation Studies as Topic
1
1991
193
0.020
Why?
Hormones
1
1991
129
0.020
Why?
Soft Tissue Neoplasms
1
1991
80
0.020
Why?
Cells, Cultured
2
2013
3582
0.020
Why?
Glioblastoma
1
1993
256
0.020
Why?
In Situ Hybridization
1
2010
304
0.020
Why?
Precipitin Tests
1
1989
73
0.020
Why?
Prospective Studies
1
2021
5949
0.020
Why?
Risk Factors
1
2003
8453
0.020
Why?
Radionuclide Imaging
1
1989
125
0.020
Why?
Odds Ratio
1
1992
954
0.020
Why?
Protein Multimerization
1
2010
141
0.020
Why?
Lymph Nodes
1
1991
309
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
683
0.020
Why?
Drug Interactions
1
2009
354
0.020
Why?
Membrane Potential, Mitochondrial
1
2007
49
0.020
Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
Why?
Cytochromes c
1
2007
64
0.020
Why?
Amino Acid Sequence
3
1998
1579
0.020
Why?
Biomarkers
1
2017
3342
0.020
Why?
Male
3
2023
55563
0.020
Why?
Caspase 10
1
2006
5
0.020
Why?
Aging
2
2002
1553
0.020
Why?
Caspase 2
1
2006
14
0.020
Why?
Caspase 8
1
2006
47
0.020
Why?
Caspase 9
1
2006
47
0.020
Why?
Cysteine Endopeptidases
1
2006
51
0.020
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
11
0.020
Why?
Caspase 7
1
2006
22
0.020
Why?
Eukaryotic Initiation Factor-4E
1
2006
25
0.020
Why?
Vero Cells
1
2006
51
0.020
Why?
Cytosol
1
2006
193
0.020
Why?
Isoenzymes
1
2007
284
0.020
Why?
Promoter Regions, Genetic
1
2010
991
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2007
182
0.020
Why?
Base Sequence
2
2003
1672
0.020
Why?
Virus Assembly
1
2006
77
0.020
Why?
Adolescent
2
2021
17117
0.020
Why?
Protein Binding
1
2010
1568
0.020
Why?
Taxoids
1
2004
94
0.020
Why?
Mice, Inbred C57BL
2
2003
4136
0.020
Why?
Protein Processing, Post-Translational
1
2006
350
0.020
Why?
DNA, Complementary
1
2003
233
0.010
Why?
Melanoma, Experimental
1
2003
86
0.010
Why?
Cell Adhesion
1
2003
385
0.010
Why?
Platelet Membrane Glycoproteins
1
2002
38
0.010
Why?
Exons
2
1993
278
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
54
0.010
Why?
Gene Targeting
1
2002
57
0.010
Why?
Templates, Genetic
1
2001
26
0.010
Why?
Molecular Sequence Data
2
1998
2292
0.010
Why?
Substrate Specificity
1
2002
284
0.010
Why?
Mice, Inbred BALB C
1
2003
847
0.010
Why?
DNA Footprinting
1
2000
19
0.010
Why?
DNA, Superhelical
1
2000
9
0.010
Why?
Genes, erbB
1
2000
2
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
91
0.010
Why?
Ploidies
1
2000
19
0.010
Why?
Proto-Oncogene Proteins c-ets
1
2000
49
0.010
Why?
Macromolecular Substances
1
2000
139
0.010
Why?
Pathology, Clinical
1
2000
33
0.010
Why?
Gene Silencing
1
2000
159
0.010
Why?
Multicenter Studies as Topic
1
2000
223
0.010
Why?
Genetic Therapy
1
2000
234
0.010
Why?
Receptors, Cell Surface
1
2000
283
0.010
Why?
Forecasting
1
2000
370
0.010
Why?
Binding Sites
1
2000
960
0.010
Why?
Nucleic Acid Conformation
1
2000
501
0.010
Why?
ras Proteins
1
1998
126
0.010
Why?
Chromosomes, Human, Pair 13
1
1996
17
0.010
Why?
Chromosomes, Human, Pair 3
1
1996
50
0.010
Why?
Chromosomes, Human, Pair 11
1
1996
61
0.010
Why?
Adenine
1
1998
198
0.010
Why?
Immunoblotting
1
1997
281
0.010
Why?
Heterozygote
1
1996
240
0.010
Why?
Hyaluronic Acid
1
1998
186
0.010
Why?
Melanoma
1
2002
577
0.010
Why?
Societies, Medical
1
2000
688
0.010
Why?
United States
2
2004
12165
0.010
Why?
Protein Isoforms
1
1997
315
0.010
Why?
Transcription, Genetic
1
2000
1022
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1995
29
0.010
Why?
Factor VIII
1
1995
51
0.010
Why?
Cyclin D1
1
1995
58
0.010
Why?
Randomized Controlled Trials as Topic
1
2000
1163
0.010
Why?
Single-Blind Method
1
1995
259
0.010
Why?
Observer Variation
1
1995
294
0.010
Why?
Alleles
1
1996
694
0.010
Why?
Biopsy
1
1995
1027
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1991
53
0.010
Why?
Peripheral Nerves
1
1991
63
0.010
Why?
DNA
1
1996
1104
0.010
Why?
Risk Assessment
1
2000
2976
0.010
Why?
Protein Conformation
1
1993
636
0.010
Why?
Polymorphism, Genetic
1
1993
576
0.010
Why?
Lung Neoplasms
1
2002
2166
0.010
Why?
Glioma
1
1991
289
0.000
Why?
Cerebral Cortex
1
1991
486
0.000
Why?
Child
1
1993
16611
0.000
Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)